DANIEL J STARKS
CIK 902132 · Chairman, CEO & President · last filed 2026-04-28
DANIEL J STARKS is a Chairman, CEO & President who has filed 85 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for ABT, was dated Apr 28, 2026. Across all open-market trades the lifetime net is −$171.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $772.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$772.22M
3
85
-$171.17M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ABT | Director | 6,751,361 | $114.38 | $772.22M | -$25.67M | 21 | 2026-04-28 |
| ST JUDE MEDICAL, LLC (STJ) Delisted | Chairman, CEO & President | 6,319,888 | — | — | -$145.50M | 58 | 2016-12-20 |
| UROLOGIX INC (ULGX) Delisted | Director | 30,000 | — | — | $0 | 2 | 2008-11-13 |
Recent Filings
85 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-28 | ABT | Mixed | +12,286 | $926.5K | EDGAR |
| 2026-02-06 | ABT | Buy (P) | +10,000 | $1.09M | EDGAR |
| 2025-04-29 | ABT | Grant (A) | +1,635 | $0 | EDGAR |
| 2024-04-30 | ABT | Grant (A) | +1,866 | $0 | EDGAR |
| 2023-10-30 | ABT | Sell (S) | −50,000 | -$4.70M | EDGAR |
| 2023-10-26 | ABT | Notice (144) | −50,000 | -$4.65M | EDGAR |
| 2023-07-28 | ABT | Sell (S) | −50,000 | -$5.69M | EDGAR |
| 2023-07-27 | ABT | Notice (144) | −50,000 | -$5.69M | EDGAR |
| 2023-05-02 | ABT | Notice (144) | −50,000 | -$5.55M | EDGAR |
| 2023-05-02 | ABT | Mixed | −48,184 | -$5.55M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.